Drug intelligence / Profile preview

Yujieli

Development stage: Unknown

Overview

Yujieli (愈结力) is a drug evaluated in clinical trials for its efficacy and safety as nutritional support therapy in patients with newly diagnosed active pulmonary tuberculosis accompanied by malnutrition. The drug is being studied in a randomized, controlled, multicenter clinical trial to assess its role as an adjunctive treatment to standard anti-tuberculosis therapy. Its mechanism of action appears to be related to improving nutritional status and supporting recovery during tuberculosis treatment[1].

Brand names: Yujieli
Other names: 愈结力

Beyond the preview

Go deeper on Yujieli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yujieli.

Explore the full profile